Abstract:Osteoarthritis (OA), characterized by joint malfunction and chronic disability, is the most common form of arthritis. Clinical and animal experiments reveal that age-related OA is associated with many factors such as age, sex, trauma, and obesity. One of the most influential and modifiable risk factors is obesity. Obesity not only increases mechanical stress on the tibiofemoral cartilage, but also leads to a higher prevalence of OA in non-weight-bearing areas. There is a link between obesity and inflammation. Adipose tissues play a crucial role in this context because they are the major source of cytokines, chemokines, and metabolically-active mediators named adipokines. The adipokines, including adiponectin and leptin, have been demonstrated to regulate inflammatory immune responses in cartilage. Obese people and animals show a higher level of serum tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL)-1β and IL-6, all of which are produced by macrophages derived from adipose tissue. These pro-inflammatory cytokines regulate the proliferation and apoptosis of adipocytes, promote lipolysis, inhibit lipid synthesis and decrease blood lipids through autocrine and paracrine mechanisms. Elevated levels of TNF-α, IL-1 and IL-6 have been found in the synovial fluid, synovial membrane, subchondral bone and cartilage of OA patients, confirming their important roles in OA pathogenesis. TNF-α, IL-6 and IL-1 are the factors released by fat to negatively regulate cartilage directly. Moreover, TNF-α, IL-1 and IL-6 can induce the production of other cytokines, matrix metalloproteinases (MMPs) and prostaglandins and inhibit the synthesis of proteoglycans and type II collagen; thus, they play a pivotal role in cartilage matrix degradation and bone resorption in OA. Activated chondrocytes also produce MMP-1, MMP-3, MMP-13, and aggrecanase 1 and 2 (ADAMTS-4, ADAMTS-5). In addition, IL-1, TNF-α and IL-6 may cause OA indirectly by regulating release of adiponectin and leptin from adipocytes. In this review, we first summarize the relationship between obesity and inflammation. Then we summarize the roles of IL-1, TNF-α and IL-6 in OA. We further discuss how IL-1, TNF-α and IL-6 regulate the communication between fat and OA, and their pathological roles in obesity-related OA. Lastly, we discuss the possibility of using the pro-inflammatory signaling pathway as a therapeutic target to develop drugs for obesity-related OA.

Obesity-induced fibrosis in osteoarthritis: Pathogenesis, consequences and novel therapeutic opportunities

Obesity and Inflammation – Targets for OA Therapy

Cartilage tissue engineering for obesity-induced osteoarthritis: Physiology, challenges, and future prospects

Pro-inflammatory Cytokines: the Link Between Obesity and Osteoarthritis

Obesity defined molecular endotypes in the synovium of patients with osteoarthritis provides a rationale for therapeutic targeting of fibroblast subsets

Cross-Communication Between Knee Osteoarthritis and Fibrosis: Molecular Pathways and Key Molecules

Obesity, Metabolic Syndrome, and Osteoarthritis Require Integrative Understanding and Management

Obesity, Inflammation, and Immune System in Osteoarthritis

Our biology working against us in obesity: A narrative review on implications for management of osteoarthritis

Pathogenesis Progress of Obesity Environment in Promoting Adipose Tissue Fibrosis

Osteoarthritis Is a Low-Grade Inflammatory Disease: Obesity's Involvement and Herbal Treatment

Metabolic stress-induced joint inflammation and osteoarthritis

Pathogenesis and clinical management of obesity-related knee osteoarthritis: Impact of mechanical loading

On the pathogenesis of obesity-associated osteoarthritis

Systemic and joint adipose tissue lipids and their role in osteoarthritis

Osteoarthritis: Novel Molecular Mechanisms Increase Our Understanding of the Disease Pathology

Challenges and opportunities in obesity: the role of adipocytes during tissue fibrosis

Obesity-Related Knee Osteoarthritis—Current Concepts

Fibrotic pathways and fibroblast-like synoviocyte phenotypes in osteoarthritis

The Emerging Role of Adipokines in Osteoarthritis: a Narrative Review.

Cellular and Molecular Mechanisms Associating Obesity to Bone Loss